Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Price Performance

STRM stock opened at $3.42 on Thursday. Streamline Health Solutions has a 1 year low of $1.85 and a 1 year high of $9.75. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. The stock’s 50 day moving average price is $2.62 and its 200 day moving average price is $5.22. The firm has a market cap of $14.45 million, a P/E ratio of -0.69 and a beta of 1.67.

Streamline Health Solutions (NASDAQ:STRM) last posted its earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.15). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The company had revenue of $4.48 million during the quarter.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.